« Back
Home /
Micafungin (sodium)

Micafungin (sodium)

Item no.	HY-16321-25mg
Manufacturer	MedChem Express
CASRN	208538-73-2
Amount	25 mg
Quantity options	100 mg 10 mM/1 mL 10 mg 1 mg 25 mg 50 mg 5 mg
Category	Metabolism Cholesterol & Lipid Metabolism Enzymes Other Fatty Acid Enzymes Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Purity	98.91
Citations	[1]Bazzi W, et al. The inhibitory effect of micafungin on biofilm formation by Pseudomonas aeruginosa. Biofouling. 2013 Jul 23.\|[2]Kai H, et al. Synergistic antifungal activity of KB425796-C in combination with micafungin against Aspergillus fumigat us and its efficacy in murine infection models. J Antibiot (Tokyo). 2013 Jun 12.\|[3]Tawara S, Ikeda F, Maki K, et al. In vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi. Antimicrob Agents Chemother. 2000;44(1):57-62. \|[4]Ikeda F, Wakai Y, Matsumoto S, et al. Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of disseminated candidiasis and aspergillosis. Antimicrob Agents Chemother. 2000;44(3):614-618. \|[5]Mikamo H, Sato Y, Tamaya T. In vitro antifungal activity of FK463, a new water-soluble echinocandin-like lipopeptide. J Antimicrob Chemother. 2000;46(3):485-487. Antimicrob Agents Chemother. 2023 Jul 10;e0054323.\|Appl Microbiol Biotechnol. 2025 Jan 24;109(1):21.\|bioRxiv. 2024 May 14.\|Chem Biol Interact. 2024 Jul 31:400:111179.\|J Clin Microbiol. 2017 Jun;55(6):1883-1893.\|PLoS Negl Trop Dis. 2019 Aug 20;13(8):e0007681. \|Sci Rep. 2017 Feb 17;7:42886.\|bioRxiv. 2025 Feb 6:2025.02.05.636768.\|Infect Drug Resist. 2022: 7459-7473.\|J Antimicrob Chemother. 2020 Aug 1;75(8):2133-2140.\|J Microbiol Methods. 2021 Sep 10;106327.\|Microorganisms. 2023 Jun 18, 11(6), 1608.\|Microorganisms. 2023, 11(1), 23.\|mSphere. 2018 Nov 14;3(6). pii: e00547-18.\|mSphere. 2020 Oct 28;5(5):e00821-20.\|Mycoses. 2021 Mar;64(3):282-291.
Smiles	O=S(OC1=CC([C@H](O)[C@@H](O)C(NC(C2N(C(C(NC([C@]([H])(C[C@@H](O)[C@@H](O)NC(C3N(C(C([C@H](O)CC(N)=O)N4)=O)C[C@H](C)[C@@H]3O)=O)NC(C5=CC=C(C6=NOC(C7=CC=C(OCCCCC)C=C7)=C6)C=C5)=O)=O)[C@H](O)C)=O)C[C@H](O)C2)=O)C4=O)=CC=C1O)(O[Na])=O
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	FK 463 (sodium)
Shipping Condition	Room temperature
Available
Manufacturer - Type	Reference compound
Manufacturer - Applications	COVID-19-immunoregulation
Manufacturer - Targets	Antibiotic; Fungal
Shipping Temperature	Room Temperature
Storage Conditions	4°C (Powder, sealed storage, away from moisture and light)
Molecular Weight	1292.26
Product Description	Micafungin sodium (FK 463 sodium) is an antifungal agent which inhibits 1, 3-beta-D-glucan synthesis.
Manufacturer - Research Area	Infection; Cancer
Solubility	DMSO: ≥ 100 mg/mL\|H2O: 100 mg/mL (ultrasonic)
Manufacturer - Pathway	Anti-infection
Clinical information	Launched

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-16321-25mg-safety-datasheet.pdf